Targeting phenol-soluble modulin α3-driven M1 macrophage polarization and necroptosis mitigates MRSA infection in

Bo Ma1, Zhi Li1, Hua Xu2

  • 1Laboratory of Toxicant Analysis, Academy of Military Medical Sciences, Beijing, China.

Nature Communications
|March 28, 2026
PubMed

Insights

Novel research reveals how methicillin-resistant Staphylococcus aureus (MRSA) virulence factor PSMα3 drives infection by promoting M1 macrophage polarization and necroptosis. Targeting STAT1 with fludarabine offers a promising anti-virulence strategy against MRSA.

Area of Science:

  • Microbiology
  • Immunology
  • Pharmacology

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) presents a significant global health challenge due to rising antibiotic resistance and high mortality rates.
  • Phenol-soluble modulin α3 (PSMα3), a key MRSA virulence factor, contributes to pathogenesis and immune evasion, but its precise mechanisms are not fully understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which PSMα3 contributes to MRSA virulence.
  • To identify potential therapeutic targets for combating MRSA infections.

Main Methods:

  • Investigated the role of PSMα3 in M1 macrophage polarization and necroptosis.
  • Examined the interaction between interferon-stimulated gene factor 3 (ISGF3) and necrosome complexes, identifying formyl peptide receptor 2 (FPR2) as the key receptor.
  • Utilized the clinically approved drug fludarabine to target signal transducer and activator of transcription 1 (STAT1) in murine models of MRSA sepsis and pneumonia.

Main Results:

  • Demonstrated that PSMα3 promotes both M1 macrophage polarization and necroptosis.
  • Established a mechanistic link between ISGF3 and necrosome complexes via FPR2.
  • Showed that fludarabine effectively mitigates MRSA infection in vivo by targeting STAT1.

Conclusions:

  • PSMα3-mediated M1 polarization and necroptosis are critical for MRSA pathogenesis.
  • Targeting the ISGF3-necrosome interaction presents a viable therapeutic strategy.
  • Fludarabine targeting of STAT1 offers a promising anti-virulence approach against MRSA infections.